From Research to Business Development & Licensing -- When science and business make a perfect blend"
Being able to link science and business by "speaking both languages" is a great advantage when playing a managerial role in a biotechnology company. Mathieu will be discussing how he is able to use the knowledge he acquired by combining his entrepreneurial venture experience with his training in fundamental life science.
Speaker: Mathieu Boudreau, Ph.D., Manager, Business Development, Aegera Therapeutics Inc.
REGISTRATION
Registration is free and required. Registration is now closed.
Mathieu is Manager of Business Development at Aegera Therapeutics, a clinical stage biotechnology company focused on developing drugs that control apoptosis for the treatment of cancer and neuropathic pain/neuropathies. In this capacity, he is responsible for all aspects of business development, licensing, and marketing. He also works closely with Aegera’s Executive team in activities related to in-licensing and merger & acquisition opportunities. Mathieu joined Aegera in 2005 as a Senior Analyst in the Business Development group. Prior to joining Aegera, Mathieu acquired entrepreneurial experience in a start-up medical device company, where he was involved in all aspects of the company, including seed financing, business development, licensing, research collaborations and marketing. Mathieu received a Ph.D. in Neuroscience from McGill University, where his doctoral work, in the laboratory of Dr. David R. Kaplan at the Montreal Neurological Institute, focused on mechanisms of protein kinase regulation in apoptosis.